Meet The Company Offering An Innovative Medication-Free Approach To Better Pelvic Floor Health, Bringing Female Urinary Incontinence Out Of The Closet June 17, 2021
Grail Will Begin Selling Its Multi-Cancer Blood Test. It Could Be the Start of a Huge Market. June 4, 2021
J&J-Backed Pulmocide Fills its Lungs with $92M Series C to Fund Phase 3, Ahead of Possible IPO May 27, 2021
A UK Antifungal Player with a Big Pharma Pedigree Bags Fresh Round of Cash as it Races Toward Late-Stage Trial May 27, 2021
